NCT02159547

IV Dexketoprofen vs Placebo in Migranie Attack

Study of Comparing Dexketoprofen to Placebo in Migraine Attack

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 224 (actual)
• Sponsor: Akdeniz University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

Detailed description

Migraine attack is one of the most leading causes presentations to emergency department. Patients with migraine attack seek urgent care to cease their pain. There are so many interventions defined in the medical literature that can be used in migraine attacks. However, as a IV drug, dexketoprofen; little known whether IV dexketoprofen is superior to placebo or not. In the present study we aimed to determine the effects of IV dexketoprofen in migraine attack in emergency department.

Conditions

• Migraine

Interventions

Type	Name	Description
DRUG	Dexketoprofen	50 mg intravenous arveles in 50 ml saline in 5 minutes
OTHER	Normal Saline	50 ml normal saline

Timeline

• Start date: 2014-05-01
• Primary completion: 2014-08-01
• Completion: 2014-08-01
• First posted: 2014-06-10
• Last updated: 2015-07-23
• Results posted: 2015-07-23

Locations

1 site across 1 country: Turkey (Türkiye)